Speed Your Neuroscience Trial

Developing a drug to treat diseases of Neuroscience is extraordinarily challenging both clinically and operationally. Challenges can include patient heterogeneity, a lack of biomarkers, subjective and insensitive rating scales, enrolling patients at the earliest stage in their disease progression and lengthy trial durations. Patients can be particularly skeptical of the perceived risk and averse to the high burden in these disease areas, making trial recruitment slow and difficult. And complex study designs with assessments put a high burden on sites that lead to challenges in site selection. Covance focuses on the scientific, medical and operational aspects of Neuroscience studies to help you overcome these hurdles and accelerate your development timeline. Find out more.